Ginkgo Bioworks and the Ministry of Health of the Republic of Botswana Announce Plans to Develop and Implement New Biosecurity Capabilities in Botswana Life Science Investing
Anti-TIGIT Domvanalimab-Containing Study Arms Improve Progression-Free Survival Compared to Anti-PD1 Alone in Phase 2 Non-Small Cell Lung Cancer Study Pharmaceutical Investing
U.S. FDA Approves VRAYLAR® as an Adjunctive Treatment for Major Depressive Disorder Pharmaceutical Investing
Ambrx Biopharma Inc. Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price Life Science Investing
AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS® for Functional Constipation in Children and Adolescents 6 to 17 Years of Age Pharmaceutical Investing
Gilead Sciences: Latinas Contra Cancer Empowers Patients To Advocate for Change Pharmaceutical Investing
Bristol Myers Squibb to Report Results for Fourth Quarter 2022 on February 2, 2023 Pharmaceutical Investing
